Home
Home

Ilaris

Second FDA thumbs-up for Novartis Ilaris

Second FDA thumbs-up for Novartis Ilaris
Pharma Times, UK

Novartis touts new data on Certican, Ilaris

Novartis touts new data on Certican, Ilaris
Fierce Pharma

Novartis drug helps in severe childhood arthritis

Novartis drug helps in severe childhood arthritis
Reuters

FDA asks Novartis for more data on gout drug

FDA asks Novartis for more data on gout drug
Reuters

FDA Is Urged To Suspend Trials Of Novartis Drug

FDA Is Urged To Suspend Trials Of Novartis Drug
Pharmalot

FDA votes against Novartis gout drug: WSJ

FDA votes against Novartis gout drug: WSJ
Marketwatch

US FDA staff-Novartis gout drug data 'complicated'

US FDA staff-Novartis gout drug data 'complicated'
Reuters

Novartis Says Experimental Gout Drug is Effective

Novartis Says Experimental Gout Drug is Effective
WSJ Online

News

A Meaningless FDA Approval ... for Now
Motley Fool
»

News

The FDA O.K.'s Novartis' Ilaris
Businessweek
»